Suppression of lncRNA HOXA11-AS/miR-124 Axis Inhibits Glioma Progression

被引:3
|
作者
He, Yishan [1 ]
Qiu, Xinguang [2 ]
机构
[1] Zhengzhou Univ, Dept Breast Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Thyroid Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China
关键词
Glioma; miR-124; lncRNA HOXA11-AS; Cell proliferation; Invasion; Apoptosis; LONG NONCODING RNA; CELL-PROLIFERATION; POOR-PROGNOSIS; INVASION; CANCER; NEUROPATHOLOGY; EXPRESSION; APOPTOSIS; SPONGE; GROWTH;
D O I
10.1007/s12013-021-01007-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our aim was to clarify the regulations of lncRNA HOXA11-AS (HOXA11-AS) played on the progression of glioma as well as to investigate the mechanisms by which HOXA11-AS modulated development of glioma. This study confirmed the regulations of miR-124 and HOXA11-AS on the progression of glioma. Here, HOXA11-AS was overexpressed and miR-124 was underexpressed in glioma. Expression of miR-124 was negatively related to that of HOXA11-AS. Silencing of HOXA11-AS suppressed cell proliferation, invasion, and promoted apoptosis in glioma cells in vitro. Moreover, inhibition of HOXA11-AS expression repressed glioma xenograft tumor growth. Expression of miR-124 was repressed by HOXA11-AS functioning as sponge. In addition, miR-124 knockdown partially abolished the inhibitory roles of HOXA11-AS downregulation in glioma cells. Conclusively, this study suggested that silencing of HOXA11-AS restrained proliferation, invasion, induced apoptosis of glioma cells, and repressed xenograft growth via modulating miR-124 expression and thus inhibited glioma progression.
引用
收藏
页码:815 / 822
页数:8
相关论文
共 50 条
  • [21] HOXA11-AS promotes the progression of oral squamous cell carcinoma by targeting the miR-518a-3p/PDK1 axis
    Li, Baojun
    Wang, Wei
    Miao, Susheng
    Li, Guofu
    Lv, Yuanjing
    Xiang, Cheng
    Pei, Rong
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [22] LncRNA MALAT1 knockdown inhibits cell migration and invasion by suppressing autophagy through miR-384/GOLM1 axis in glioma
    Ma, R.
    Zhang, B-W
    Zhang, Z-B
    Deng, Q-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (05) : 2601 - 2615
  • [23] LncRNA HOXA11-AS Aggravates Keloid Progression by the Regulation of HOXA11-AS-miR-205-5p-FOXM1 Pathway
    Su, Xiaoguang
    Ma, Yaohui
    Wang, Qing
    Gao, Yanjun
    JOURNAL OF SURGICAL RESEARCH, 2021, 259 : 284 - 295
  • [24] LINC01234 promotes multiple myeloma progression by regulating miR-124-3p/GRB2 axis
    Chen, Xueyan
    Liu, Yin
    Yang, Zihua
    Zhang, Jiang
    Chen, Shaoqian
    Cheng, Jing
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (10): : 6600 - 6618
  • [25] miR-124 radiosensitizes human glioma cells by targeting CDK4
    Deng, Xubin
    Ma, Lei
    Wu, Minhua
    Zhang, Gong
    Jin, Chuan
    Guo, Yuping
    Liu, Ruilei
    JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (03) : 263 - 274
  • [26] Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells
    Xu, Chenyang
    He, Tao
    Li, Zhenjiang
    Liu, Honglin
    Ding, Bingqian
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 1504 - 1513
  • [27] The IncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2
    Xu, C-H
    Xiao, L-M
    Liu, Y.
    Chen, L-K
    Zheng, S-Y
    Zeng, E-M
    Li, D-H
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (01) : 241 - 252
  • [28] Long non-coding RNA UCA1 promotes retinoblastoma progression by modulating the miR-124/c-myc axis
    Wang, Lan
    Wu, Mingxing
    Zhou, Xiyuan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (03): : 1592 - 1605
  • [29] Long non-coding RNA HOXA11-AS accelerates the progression of keloid formation via miR-124-3p/TGFβR1 axis (Publication with Expression of Concern. See MAR, 2023)
    Jin, Jun
    Jia, Zhen-Hua
    Luo, Xiao-Hua
    Zhai, Hong-Feng
    CELL CYCLE, 2020, 19 (02) : 218 - 232
  • [30] HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers
    Lu, Cheng-Wei
    Zhou, Dan-Dan
    Xie, Tian
    Hao, Ji-Long
    Pant, Om Prakash
    Lu, Cheng-Bo
    Liu, Xiu-Fen
    CANCER MEDICINE, 2018, 7 (08): : 3792 - 3799